EPISODE · Jan 11, 2016 · 6 MIN
Expanding Immunotheapy Benefit in Metastatic RCC
from Journal of Clinical Oncology (JCO) Podcast · host Brian I. Rini
Discussion of a phase I trial of the checkpoint inhibitor atezolizumab in metastatic renal carcinoma.
NOW PLAYING
Expanding Immunotheapy Benefit in Metastatic RCC
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m